Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Carbylan, KalVista Announce Share Purchase Agreement
Friday, June 24, 2016
Collaboration aims to focus on the discovery, development and commercialization of plasma kallikrein inhibitors for the treatment of HAE and DME.

Merck, Afferent Pharmaceuticals Collaborate
Friday, June 24, 2016
Collaboration aims to acquire all outstanding stock of Afferent in exchange for an upfront payment of $500 million in cash.

Recipharm Announces Global Serialisation Collaboration
Thursday, June 23, 2016
Company has announced partnership with Marchesini, SEA Vision and TraceLink to introduce new serialisation capabilities.

Valeant Announces Significant Investments in Canadian Operations
Thursday, June 23, 2016
Company will invest $15 million in its Steinbach, Manitoba facility including $7 million to upgrade product manufacturing technology and $8 million for the transfer of North American production of Xifaxan® and Apriso®.

Strata Completes Series A Financing
Tuesday, June 21, 2016
The financing will fuel Strata's tumor sequencing operation and implementation of the Strata trial.

What Makes a Good Scientist?
Wednesday, June 15, 2016
It’s the journey, not just the destination that counts as a scientist when conducting research.

Envigo Appoints Patricia Henahan as New Chief Financial Officer
Saturday, June 11, 2016
Company has announced that it has appointed Patricia Henahan to the position of Chief Financial Officer. She has extensive financial experience.

Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1143 in Ovarian Cancer
Thursday, June 09, 2016
Company has announced the start of a phase II clinical trial for Debio 1143 in combination with standard of care Carboplatin and Paclitaxel in Epithelial Ovarian Cancer.

Aprea Ab Announces Efficacy And Safety Data In High-Grade Serous Ovarian Cancer
Wednesday, June 08, 2016
The company claims that APR-246 can be successfully combined with standard chemotherapy for ovarian cancer with minimal additional toxicity.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 4310
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!